Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 5 (May)

1. The distinct effects of a butanol fraction of Bidens pilosa plant extract on the development of Th1-mediated diabetes and Th2-mediated airway inflammation in mice.
   J Biomed Sci, 12(1): 79-89. [Abstract] [Full-text]
2. Inflammation, stress, and diabetes.
   J Clin Invest, 115(5): 1111-9. [Abstract] [Full-text]
3. Evaluating diabetic foot infection with magnetic resonance imaging: Kuwait experience.
   Med Princ Pract, 14(3): 165-72. [Abstract] [Full-text]
4. Diabetes insipidus in the third trimester of pregnancy.
   Obstet Gynecol, 105(5): 1173-6. [Abstract] [Full-text]
5. Supplementation with alpha-linolenic acid-rich diacylglycerol suppresses fatty liver formation accompanied by an up-regulation of beta-oxidation in Zucker fatty rats.
   Biochim Biophys Acta, 1733(2): 224-31. [Abstract] [Full-text]
6. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
   Brain Res, 1044(1): 76-86. [Abstract] [Full-text]
7. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
   Life Sci, 77(2): 149-59. [Abstract] [Full-text]
8. Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients.
   Am J Surg, 189(5): 552-7; discussion 557. [Abstract] [Full-text]
9. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.
   J Am Coll Cardiol, 45(9): 1449-57. [Abstract] [Full-text]
10. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.
    J Am Coll Cardiol, 45(9): 1413-8. [Abstract] [Full-text]
11. Calpain inhibition and insulin action in cultured human muscle cells.
    Mol Genet Metab, 85(1): 54-60. [Abstract] [Full-text]
12. Hypoglycaemic activity of Retama raetam in rats.
    Phytother Res, 19(2): 125-8. [Abstract] [Full-text]
13. Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.
    J Clin Invest, 115(5): 1323-32. [Abstract] [Full-text]
14. Mood and cognitive function in elderly diabetic patients living in care facilities.
    Dement Geriatr Cogn Disord, 19(5): 369-75. [Abstract] [Full-text]
15. Detection of a novel familial catalase mutation (Hungarian type D) and the possible risk of inherited catalase deficiency for diabetes mellitus.
    Electrophoresis, 26(9): 1646-9. [Abstract] [Full-text]
16. Extracellular lysosome-associated membrane protein-1 (LAMP-1) mediates autoimmune disease progression in the NOD model of type 1 diabetes.
    Eur J Immunol, 35(5): 1501-9. [Abstract] [Full-text]
17. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Acta Diabetol, 42: S42-9. [Abstract] [Full-text]
18. Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers.
    Acta Diabetol, 42: S26-32. [Abstract] [Full-text]
19. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction.
    Acta Diabetol, 42: S17-25. [Abstract] [Full-text]
20. Gender, body mass index and socio-demographic variables associated with knowledge about type 2 diabetes mellitus among 13,293 Mexican students.
    Acta Diabetol, 42(1): 36-45. [Abstract] [Full-text]
21. Lack of suppression of plasma glucagon levels in late pregnancy persists postpartum only in women with previous gestational diabetes mellitus.
    Acta Diabetol, 42(1): 31-5. [Abstract] [Full-text]
22. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone.
    Acta Diabetol, 42(1): 23-30. [Abstract] [Full-text]
23. Autonomic, endothelial function and the analysis of gait in patients with type 1 and type 2 diabetes.
    Acta Diabetol, 42(1): 7-15. [Abstract] [Full-text]
24. Long-term interactive group education for type 1 diabetic patients.
    Acta Diabetol, 42(1): 1-6. [Abstract] [Full-text]
25. The A2 milk case: a critical review.
    Eur J Clin Nutr, 59(5): 623-31. [Abstract] [Full-text]
26. Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus.
    Pediatrics, 115(5): 1320-4. [Abstract] [Full-text]
27. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus.
    Pediatrics, 115(5): 1315-9. [Abstract] [Full-text]
28. Obesity at the onset of diabetes in an ethnically diverse population of children: what does it mean for epidemiologists and clinicians?
    Pediatrics, 115(5): e553-60. [Abstract] [Full-text]
29. Pancreas donation for islet transplantation.
    Transplant Proc, 37(3): 1560-1. [Abstract] [Full-text]
30. Kidney-pancreas transplants: is it so difficult to start a program?
    Transplant Proc, 37(3): 1455-6. [Abstract] [Full-text]
31. Minimal model analysis in nondiabetic renal transplant recipients with hepatitis C.
    Transplant Proc, 37(3): 1446-8. [Abstract] [Full-text]
32. Pancreas islet transplantation in patients with type 1 diabetes mellitus after kidney transplantation.
    Transplant Proc, 37(3): 1443-5. [Abstract] [Full-text]
33. Diabetes mellitus in patients with schizophrenia in Taiwan.
    Prog Neuropsychopharmacol Biol Psychiatry, 29(4): 523-7. [Abstract] [Full-text]
34. Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat.
    J Nutr Biochem, 16(5): 312-20. [Abstract] [Full-text]
35. Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithm.
    Eur J Obstet Gynecol Reprod Biol, 120(1): 39-44. [Abstract] [Full-text]
36. Should minimal blood glucose variability become the gold standard of glycemic control?
    J Diabetes Complications, 19(3): 178-81. [Abstract] [Full-text]
37. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
    J Diabetes Complications, 19(3): 168-77. [Abstract] [Full-text]
38. Evaluation of balance and physical fitness in diabetic neuropathic patients.
    J Diabetes Complications, 19(3): 160-4. [Abstract] [Full-text]
39. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    J Diabetes Complications, 19(3): 147-54. [Abstract] [Full-text]
40. Protein oxidation in Type 2 diabetic patients on hemodialysis.
    J Diabetes Complications, 19(3): 142-6. [Abstract] [Full-text]
41. Bacteriological study of diabetic foot infections.
    J Diabetes Complications, 19(3): 138-41. [Abstract] [Full-text]
42. Prevalence of antiphospholipid antibodies is not different in Chilean diabetic patients and normal individuals.
    J Diabetes Complications, 19(3): 133-7. [Abstract] [Full-text]
43. Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.
    J Diabetes Complications, 19(3): 128-32. [Abstract] [Full-text]
44. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients.
    J Diabetes Complications, 19(3): 123-7. [Abstract] [Full-text]
45. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Surg Infect (Larchmt), 6(1): 27-40. [Abstract] [Full-text]
46. Major ozonated autohemotherapy in chronic limb ischemia with ulcerations.
    J Altern Complement Med, 11(2): 363-7. [Abstract] [Full-text]
47. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus.
    J Altern Complement Med, 11(2): 267-74. [Abstract] [Full-text]
48. Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes.
    Biochemistry, 44(18): 6948-57. [Abstract] [Full-text]
49. Expression and distribution of kinin B1 receptor in the rat brain and alterations induced by diabetes in the model of streptozotocin.
    Synapse, 57(1): 29-37. [Abstract] [Full-text]
50. A thromboxane effect of a hydroxytyrosol-rich olive oil wastewater extract in patients with uncomplicated type I diabetes.
    Eur J Clin Nutr, 59(5): 727-30. [Abstract] [Full-text]
51. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis.
    J Pediatr, 146(5): 688-92. [Abstract] [Full-text]
52. Epidemiology of cystic fibrosis-related diabetes.
    J Pediatr, 146(5): 681-7. [Abstract] [Full-text]
53. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls.
    Clin Immunol, 115(1): 102-14. [Abstract] [Full-text]
54. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse.
    Clin Immunol, 115(1): 74-9. [Abstract] [Full-text]
55. Thymic transcription of neurohypophysial and insulin-related genes: impact upon T-cell differentiation and self-tolerance.
    J Neuroendocrinol, 17(5): 321-7. [Abstract] [Full-text]
56. Cost and benefits of a multidisciplinary intensive diabetes education programme.
    J Eval Clin Pract, 11(3): 293-303. [Abstract] [Full-text]
57. Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies.
    Diabetes Metab Res Rev, 21(3): 231-40. [Abstract] [Full-text]
58. Involvement of Ca2+/calmodulin-dependent protein kinase II in the modulation of indolamines in diabetic and hyperglycemic rats.
    J Neurosci Res, 80(4): 518-28. [Abstract] [Full-text]
59. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?
    Diabetes Metab Res Rev, 21(3): 241-52. [Abstract] [Full-text]
60. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.
    Diabetes Metab Res Rev, 21(3): 271-5. [Abstract] [Full-text]
61. Influence of diabetic metabolic state on fracture healing in spontaneously diabetic rats.
    Diabetes Metab Res Rev, 21(3): 288-96. [Abstract] [Full-text]
62. A record linkage protocol for a diabetes registry at ethnically diverse community health centers.
    J Am Med Inform Assoc, 12(3): 331-7. [Abstract] [Full-text]
63. Sildenafil in the treatment of erectile dysfunction in men with diabetes: demand, efficacy and patient satisfaction.
    Int J Impot Res, 17(3): 264-9. [Abstract] [Full-text]
64. Diabetes per se and metabolic state influence gene expression in tissue-dependent manner of BB/OK rats.
    Diabetes Metab Res Rev, 21(3): 281-7. [Abstract] [Full-text]
65. Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects.
    Diabetes Metab Res Rev, 21(3): 276-80. [Abstract] [Full-text]
66. Design and development of a scale measuring fear of complications in type 1 diabetes.
    Diabetes Metab Res Rev, 21(3): 264-70. [Abstract] [Full-text]
67. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
    J Clin Endocrinol Metab, 90(5): 2712-7. [Abstract] [Full-text]
68. Reduced serum homocysteine levels in type 2 diabetes.
    Nutr Metab Cardiovasc Dis, 15(2): 118-24. [Abstract] [Full-text]
69. Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors.
    Nutr Metab Cardiovasc Dis, 15(2): 109-17. [Abstract] [Full-text]
70. Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits.
    J Mol Med, 83(5): 353-61. [Abstract] [Full-text]
71. The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4alpha (HNF4A): gene associations with type 2 diabetes or altered beta-cell function among Danes.
    J Clin Endocrinol Metab, 90(5): 3054-9. [Abstract] [Full-text]
72. Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: the Funagata Study.
    Metabolism, 54(5): 669-76. [Abstract] [Full-text]
73. Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: association study and meta-analysis.
    Metabolism, 54(5): 628-33. [Abstract] [Full-text]
74. Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
    Metabolism, 54(5): 619-27. [Abstract] [Full-text]
75. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.
    Metabolism, 54(5): 590-7. [Abstract] [Full-text]
76. A retinoid X receptor antagonist, HX531, improves leptin resistance without increasing plasma leptin level in KK-Ay mice under normal dietary conditions.
    Metabolism, 54(5): 573-8. [Abstract] [Full-text]
77. Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats.
    Can J Physiol Pharmacol, 83(4): 343-55. [Abstract] [Full-text]
78. Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1?
    Endocr Dev, 9: 121-34. [Abstract] [Full-text]
79. Childhood and adolescent diabetes.
    Endocr Dev, 9: 107-20. [Abstract] [Full-text]
80. Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology.
    Endocr Dev, 9: 44-54. [Abstract] [Full-text]
81. Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice.
    Eur J Endocrinol, 152(5): 805-11. [Abstract] [Full-text]
82. Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney.
    Biochim Biophys Acta, 1740(1): 79-84. [Abstract] [Full-text]
83. Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis.
    Biochim Biophys Acta, 1740(1): 74-8. [Abstract] [Full-text]
84. Changes in ovarian steroidogenesis in insulin-resistant, type 2 diabetic Goto-Kakizaki rats after thyroidectomy and gonadotropin treatment.
    Eur J Pharmacol, 513(1): 151-7. [Abstract] [Full-text]
85. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation.
    Eur J Pharmacol, 513(1): 145-50. [Abstract] [Full-text]
86. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003.
    Eur J Vasc Endovasc Surg, 29(6): 620-7. [Abstract] [Full-text]
87. A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid.
    Clin Ther, 27(3): 320-6. [Abstract] [Full-text]
88. Subcutaneous xenotransplantation of bovine pancreatic islets.
    Biomaterials, 26(28): 5640-7. [Abstract] [Full-text]
89. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Eur J Pharmacol, 514(1): 69-78. [Abstract] [Full-text]
90. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.
    Eur J Pharmacol, 514(1): 61-7. [Abstract] [Full-text]
91. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
    Ophthalmology, 112(5): 806-16. [Abstract] [Full-text]
92. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies.
    Ophthalmology, 112(5): 799-805. [Abstract] [Full-text]
93. Diabetes and hypertension in isolated sixth nerve palsy: a population-based study.
    Ophthalmology, 112(5): 760-3. [Abstract] [Full-text]
94. Guidelines for the treatment and management of new-onset diabetes after transplantation.
    Clin Transplant, 19(3): 291-8. [Abstract] [Full-text]
95. Combined effect of probucol and insulin on cataracts of diabetic rats fed a high cholesterol diet.
    Eur J Pharmacol, 513(1): 159-68. [Abstract] [Full-text]
96. Spirituality and self-management of diabetes in African Americans.
    J Holist Nurs, 23(2): 230-50; discussion 251-4; quiz 226-7. [Abstract] [Full-text]
97. Need for eye care among older adults with diabetes mellitus in fee-for-service and managed Medicare.
    Arch Ophthalmol, 123(5): 669-75. [Abstract] [Full-text]
98. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus.
    Arch Intern Med, 165(9): 1060-5. [Abstract] [Full-text]
99. Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study.
    Arch Intern Med, 165(9): 997-1003. [Abstract] [Full-text]
100. The association of heart failure with insulin resistance and the development of type 2 diabetes.
     Am J Hypertens, 18(5): 731-7. [Abstract] [Full-text]
101. The value of empathy in dietetic consultations. A pilot study to investigate its effect on satisfaction, autonomy and agreement.
     J Hum Nutr Diet, 18(3): 181-5. [Abstract] [Full-text]
102. Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.
     Kidney Int, 67(6): 2494-9. [Abstract] [Full-text]
103. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation.
     Kidney Int, 67(6): 2415-21. [Abstract] [Full-text]
104. Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.
     Kidney Int, 67(6): 2325-9. [Abstract] [Full-text]
105. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
     Am J Physiol Renal Physiol, 288(6): F1183-90. [Abstract] [Full-text]
106. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.
     Am J Physiol Renal Physiol, 288(6): F1144-52. [Abstract] [Full-text]
107. Altered expression of selected genes in kidney of rats with lithium-induced NDI.
     Am J Physiol Renal Physiol, 288(6): F1276-89. [Abstract] [Full-text]
108. Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes.
     Am J Physiol Renal Physiol, 288(6): F1220-6. [Abstract] [Full-text]
109. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
     Am J Physiol Endocrinol Metab, 288(6): E1188-94. [Abstract] [Full-text]
110. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.
     J Gene Med, 7(5): 621-9. [Abstract] [Full-text]
111. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
     Am J Physiol Renal Physiol, 288(6): F1103-12. [Abstract] [Full-text]
112. C-reactive protein concentration is not related to islet autoimmunity status in offspring of parents with type 1 diabetes.
     Clin Immunol, 115(2): 173-7. [Abstract] [Full-text]
113. Cholestatic liver injury after glimepiride therapy.
     J Hepatol, 42(6): 944-6. [Abstract] [Full-text]
114. Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment.
     Clin Biochem, 38(6): 509-13. [Abstract] [Full-text]
115. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.
     Proc Natl Acad Sci U S A, 102(19): 6931-5. [Abstract] [Full-text]
116. Endocrine pancreatic insufficiency in chronic pancreatitis.
     Pancreatology, 5(2): 122-31. [Abstract] [Full-text]
117. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.
     Nature, 435(7039): 224-8. [Abstract] [Full-text]
118. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
     Nature, 435(7039): 220-3. [Abstract] [Full-text]
119. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives.
     Physiology (Bethesda), 20: 152-61. [Abstract] [Full-text]
120. Evaluation of simple non-invasive techniques for assessment of lower extremity arterial disease.
     Clin Physiol Funct Imaging, 25(3): 129-34. [Abstract] [Full-text]
121. Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.
     Am J Transplant, 5(6): 1332-8. [Abstract] [Full-text]
122. XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury.
     Am J Transplant, 5(6): 1297-305. [Abstract] [Full-text]
123. Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes.
     Pediatr Nephrol, 20(6): 750-8. [Abstract] [Full-text]
124. Sialadenosis of the major salivary glands in a patient with central diabetes insipidus--implications of aquaporin water channels in the pathomechanism of sialadenosis.
     Exp Clin Endocrinol Diabetes, 113(4): 205-7. [Abstract] [Full-text]
125. Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets.
     Exp Clin Endocrinol Diabetes, 113(4): 199-204. [Abstract] [Full-text]
126. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
     Exp Clin Endocrinol Diabetes, 113(4): 195-8. [Abstract] [Full-text]
127. Molecular targeting of pancreatic disorders.
     World J Surg, 29(3): 325-33. [Abstract] [Full-text]
128. Reliability of reporting of self-monitoring of blood glucose in pregnant women.
     J Obstet Gynecol Neonatal Nurs, 34(3): 329-34. [Abstract] [Full-text]
129. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
     Diabetologia, 48(5): 838-48. [Abstract] [Full-text]
130. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.
     Diabetologia, 48(5): 829-37. [Abstract] [Full-text]
131. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
     Diabetologia, 48(5): 922-30. [Abstract] [Full-text]
132. Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).
     Diabetologia, 48(5): 868-77. [Abstract] [Full-text]
133. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
     Diabetologia, 48(5): 900-5. [Abstract] [Full-text]
134. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy.
     Diabetologia, 48(5): 817-23. [Abstract] [Full-text]
135. Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus.
     Diabetologia, 48(5): 1002-7. [Abstract] [Full-text]
136. Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat.
     Diabetologia, 48(5): 931-7. [Abstract] [Full-text]
137. Islet isolation for allotransplantation: variables associated with successful islet yield and graft function.
     Diabetologia, 48(5): 906-12. [Abstract] [Full-text]
138. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects.
     Diabetologia, 48(5): 1008-16. [Abstract] [Full-text]
139. Heterogeneity in limb fatty acid kinetics in type 2 diabetes.
     Diabetologia, 48(5): 938-45. [Abstract] [Full-text]
140. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation.
     Diabetologia, 48(5): 824-8. [Abstract] [Full-text]
141. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity.
     Diabetologia, 48(5): 892-9. [Abstract] [Full-text]
142. Clinical significance of the physicochemical properties of LDL in type 2 diabetes.
     Diabetologia, 48(5): 808-16. [Abstract] [Full-text]
143. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.
     Diabetologia, 48(5): 878-85. [Abstract] [Full-text]
144. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction.
     Diabetologia, 48(5): 856-61. [Abstract] [Full-text]
145. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.
     Diabetologia, 48(5): 993-1001. [Abstract] [Full-text]
146. The risk of venous thromboembolism is markedly elevated in patients with diabetes.
     Diabetologia, 48(5): 1017-21. [Abstract] [Full-text]
147. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.
     J Ethnopharmacol, 99(2): 239-44. [Abstract] [Full-text]
148. IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes.
     Clin Immunol, 115(3): 260-7. [Abstract] [Full-text]
149. Upregulation of mRNAs coding for AMPA and NMDA receptor subunits and metabotropic glutamate receptors in the dorsal horn of the spinal cord in a rat model of diabetes mellitus.
     Brain Res Mol Brain Res, 136(1): 275-81. [Abstract] [Full-text]
150. MR imaging of the diabetic foot: diagnostic challenges.
     Radiol Clin North Am, 43(4): 747-59, ix. [Abstract] [Full-text]
151. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
     J Am Coll Cardiol, 45(10): 1622-30. [Abstract] [Full-text]
152. The sweet thing about Type 1 diabetes: a cryoprotective evolutionary adaptation.
     Med Hypotheses, 65(1): 8-16. [Abstract] [Full-text]
153. Substance abuse in young patients with type 1 diabetes: easily neglected in complex medical management.
     Intern Med J, 35(6): 359-61. [Abstract] [Full-text]
154. Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies.
     Nephrol Dial Transplant, 20(6): 1103-9. [Abstract] [Full-text]
155. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus.
     Nephrol Dial Transplant, 20(6): 1093-102. [Abstract] [Full-text]
156. Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes.
     Drug Discov Today, 10(10): 703-10. [Abstract] [Full-text]
157. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes.
     Mol Genet Metab, 85(2): 149-56. [Abstract] [Full-text]
158. Vesicle-associated membrane protein 4, a positional candidate gene on 1q24-q25, is not associated with type 2 diabetes in the Old Order Amish.
     Mol Genet Metab, 85(2): 133-9. [Abstract] [Full-text]
159. Is NF-kappaB a culprit in type 2 diabetes?
     Biochem Biophys Res Commun, 332(1): 1-3. [Abstract] [Full-text]
160. Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes.
     QJM, 98(6): 427-33. [Abstract] [Full-text]
161. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.
     Endocr Rev, 26(3): 380-92. [Abstract] [Full-text]
162. An insulin-response element-binding protein that ameliorates hyperglycemia in diabetes.
     J Biol Chem, 280(20): 20010-20. [Abstract] [Full-text]
163. Release of transgenic human insulin from gastric g cells: a novel approach for the amelioration of diabetes.
     Endocrinology, 146(6): 2610-9. [Abstract] [Full-text]
164. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study.
     Clin Sci (Lond), 108(6): 507-13. [Abstract] [Full-text]
165. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
     Clin Sci (Lond), 108(6): 497-506. [Abstract] [Full-text]
166. Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations.
     Clin Chem Lab Med, 43(4): 431-7. [Abstract] [Full-text]
167. Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy.
     J Cataract Refract Surg, 31(4): 742-9. [Abstract] [Full-text]
168. Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats.
     Exp Neurol, 194(1): 279-83. [Abstract] [Full-text]
169. Quercetin alleviates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
     Mol Nutr Food Res, 49(4): 355-60. [Abstract] [Full-text]
170. Urinary-peptide excretion by patients with and volunteers without diabetes.
     J Lab Clin Med, 145(5): 239-46. [Abstract] [Full-text]
171. An observational study of veterans with diabetes receiving weekly or daily home telehealth monitoring.
     J Telemed Telecare, 11(3): 150-6. [Abstract] [Full-text]
172. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
     J Pharm Pharmacol, 57(5): 665-9. [Abstract] [Full-text]
173. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
     J Hum Hypertens, 19(6): 429-37. [Abstract] [Full-text]
174. Fatty acid metabolism is enhanced in type 2 diabetic hearts.
     Biochim Biophys Acta, 1734(2): 112-26. [Abstract] [Full-text]
175. High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice.
     Life Sci, 77(5): 481-95. [Abstract] [Full-text]
176. Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus.
     Am J Cardiol, 95(11): 1386-8. [Abstract] [Full-text]
177. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.
     Am J Cardiol, 95(11): 1375-7. [Abstract] [Full-text]
178. Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes.
     Am J Cardiol, 95(11): 1290-4. [Abstract] [Full-text]
179. Diabetic nephropathy: the proteinuria hypothesis.
     Am J Nephrol, 25(2): 77-94. [Abstract] [Full-text]
180. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats.
     Comp Biochem Physiol C Toxicol Pharmacol, 140(2): 251-5. [Abstract] [Full-text]
181. Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats.
     Lab Invest, 85(5): 675-88. [Abstract] [Full-text]
182. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier.
     Lab Invest, 85(5): 597-607. [Abstract] [Full-text]
183. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
     Arch Intern Med, 165(10): 1179-84. [Abstract] [Full-text]
184. An association between HIV/HCV co-infection and diabetes mellitus--is there a need for routine blood glucose monitoring?
     J Clin Virol, 33(2): 176-8. [Abstract] [Full-text]
185. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection.
     J Clin Virol, 33(2): 158-67. [Abstract] [Full-text]
186. Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.
     Pharmacol Res, 52(1): 60-71. [Abstract] [Full-text]
187. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
     Eur J Pharm Sci, 25(2): 337-45. [Abstract] [Full-text]
188. Diabetes education on Turkish immigrant diabetics: predictors of compliance.
     Patient Educ Couns, 57(2): 158-61. [Abstract] [Full-text]
189. Patient empowerment: reflections on the challenge of fostering the adoption of a new paradigm.
     Patient Educ Couns, 57(2): 153-7. [Abstract] [Full-text]
190. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.
     Pain, 115(3): 254-63. [Abstract] [Full-text]
191. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established.
     Exp Hematol, 33(6): 699-705. [Abstract] [Full-text]
192. PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.
     J Control Release, 104(3): 447-60. [Abstract] [Full-text]
193. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
     Atherosclerosis, 180(2): 389-97. [Abstract] [Full-text]
194. Congenital anomaly rate in offspring of mothers with diabetes treated with insulin lispro during pregnancy.
     Diabet Med, 22(6): 803-7. [Abstract] [Full-text]
195. Quality assurance for diabetic retinopathy telescreening.
     Diabet Med, 22(6): 794-802. [Abstract] [Full-text]
196. Prevalence of undiagnosed Type 2 diabetes and impaired fasting glucose in older British men and women.
     Diabet Med, 22(6): 789-93. [Abstract] [Full-text]
197. Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
     Diabet Med, 22(6): 782-8. [Abstract] [Full-text]
198. Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes.
     Diabet Med, 22(6): 775-81. [Abstract] [Full-text]
199. Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.
     Diabet Med, 22(6): 768-74. [Abstract] [Full-text]
200. Plantar pressure distribution in Type 2 diabetic patients without peripheral neuropathy and peripheral vascular disease.
     Diabet Med, 22(6): 762-7. [Abstract] [Full-text]
201. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
     Diabet Med, 22(6): 756-61. [Abstract] [Full-text]
202. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
     Diabet Med, 22(6): 749-55. [Abstract] [Full-text]
203. The SPINK1 N34S mutation is not associated with Type 2 diabetes mellitus in a population of the USA.
     Diabet Med, 22(6): 744-8. [Abstract] [Full-text]
204. Association analysis of the variant in the regulatory subunit of phosphoinositide 3-kinase (p85alpha) with Type 2 diabetes mellitus and hypertension in the Chinese Han population.
     Diabet Med, 22(6): 737-43. [Abstract] [Full-text]
205. Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus.
     Diabet Med, 22(6): 730-6. [Abstract] [Full-text]
206. Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients.
     Diabet Med, 22(6): 723-9. [Abstract] [Full-text]
207. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
     Diabet Med, 22(6): 719-22. [Abstract] [Full-text]
208. Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes.
     Diabet Med, 22(6): 711-8. [Abstract] [Full-text]
209. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.
     Diabet Med, 22(6): 703-10. [Abstract] [Full-text]
210. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
     Diabet Med, 22(6): 697-702. [Abstract] [Full-text]
211. Risk of specific congenital abnormalities in offspring of women with diabetes.
     Diabet Med, 22(6): 693-6. [Abstract] [Full-text]
212. Dissemination of 'patient-oriented evidence that matters' on the Internet: the case of Type 2 diabetes treatment.
     Diabet Med, 22(6): 688-92. [Abstract] [Full-text]
213. Setting and negotiating targets in people with Type 2 diabetes in primary care: a cross sectional survey.
     Diabet Med, 22(6): 683-7. [Abstract] [Full-text]
214. Molecular mechanisms of insulin resistance.
     Diabet Med, 22(6): 674-82. [Abstract] [Full-text]
215. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
     J Intern Med, 257(6): 531-9. [Abstract] [Full-text]
216. Glutathione levels in patients with erectile dysfunction, with or without diabetes mellitus.
     Int J Androl, 28(3): 156-62. [Abstract] [Full-text]
217. Effect of low intensity helium-neon (He-Ne) laser irradiation on diabetic wound healing dynamics.
     Photomed Laser Surg, 23(2): 187-90. [Abstract] [Full-text]
218. The role of galanin in metabolic disorders leading to type 2 diabetes mellitus.
     Drug News Perspect, 18(3): 173-7. [Abstract] [Full-text]
219. The Ins2Akita mouse as a model of early retinal complications in diabetes.
     Invest Ophthalmol Vis Sci, 46(6): 2210-8. [Abstract] [Full-text]
220. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats.
     Invest Ophthalmol Vis Sci, 46(6): 2092-9. [Abstract] [Full-text]
221. Echocardiographic measurements in infants of diabetic mothers and macrosomic infants of nondiabetic mothers.
     J Perinat Med, 33(3): 232-5. [Abstract] [Full-text]
222. Islet cell related antibodies and type 1 diabetes associated with echovirus 30 epidemic: a case report.
     J Med Virol, 76(3): 373-7. [Abstract] [Full-text]
223. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
     Mol Endocrinol, 19(6): 1593-605. [Abstract] [Full-text]
224. Mannose-binding lectin (MBL) and vascular complications in diabetes.
     Horm Metab Res, 37: 95-8. [Abstract] [Full-text]
225. Osteoprotegerin and diabetic macroangiopathy.
     Horm Metab Res, 37: 90-4. [Abstract] [Full-text]
226. Percutaneous coronary intervention in diabetic patients: a problem?
     Horm Metab Res, 37: 83-9. [Abstract] [Full-text]
227. Multi-targeted and aggressive treatment of patients with type 2 diabetes at high risk: what are we waiting for?
     Horm Metab Res, 37: 76-82. [Abstract] [Full-text]
228. Management of the diabetic foot: surgical and organisational aspects.
     Horm Metab Res, 37: 69-75. [Abstract] [Full-text]
229. Pathogenesis of foot ulcers and the need for offloading.
     Horm Metab Res, 37: 61-8. [Abstract] [Full-text]
230. Functional abnormalities in isolated arteries from Goto-Kakizaki and streptozotocin-treated diabetic rat models.
     Horm Metab Res, 37: 56-60. [Abstract] [Full-text]
231. Endothelial dysfunction, cellular adhesion molecules and the metabolic syndrome.
     Horm Metab Res, 37: 49-55. [Abstract] [Full-text]
232. The growth hormone hypothesis - 2005 revision.
     Horm Metab Res, 37: 44-8. [Abstract] [Full-text]
233. Pericytes and the pathogenesis of diabetic retinopathy.
     Horm Metab Res, 37: 39-43. [Abstract] [Full-text]
234. Diabetic retinopathy: a review of the aarhus approach to studies on epidemiology, computerised grading, and the pathophysiology of the disease.
     Horm Metab Res, 37: 35-8. [Abstract] [Full-text]
235. AGE-RAGE and AGE Cross-link interaction: important players in the pathogenesis of diabetic kidney disease.
     Horm Metab Res, 37: 26-34. [Abstract] [Full-text]
236. The use of transgenic animals in the study of diabetic kidney disease.
     Horm Metab Res, 37: 17-25. [Abstract] [Full-text]
237. The podocyte: a major player in the development of diabetic nephropathy?
     Horm Metab Res, 37: 9-16. [Abstract] [Full-text]
238. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
     Horm Metab Res, 37: 4-8. [Abstract] [Full-text]
239. Effect of CYP3A1(23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus.
     Antimicrob Agents Chemother, 49(6): 2528-32. [Abstract] [Full-text]
240. UISESS scale for staging and classifying clinical-epidemiological risk in type 2 diabetes mellitus and for establishing multidisciplinary preventive actions.
     Prev Med, 41(1): 211-8. [Abstract] [Full-text]
241. The impact of formal diabetes education on the preventive health practices and behaviors of persons with type 2 diabetes.
     Prev Med, 41(1): 79-84. [Abstract] [Full-text]
242. Burden of disease associated with overweight and obesity among U.S. military retirees and their dependents, aged 38-64, 2003.
     Prev Med, 41(1): 63-9. [Abstract] [Full-text]
243. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
     Br J Haematol, 129(5): 597-606. [Abstract] [Full-text]
244. Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
     J Am Soc Nephrol, 16(6): 1775-80. [Abstract] [Full-text]
245. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.
     J Am Soc Nephrol, 16(6): 1711-22. [Abstract] [Full-text]
246. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.
     J Am Soc Nephrol, 16(6): 1654-60. [Abstract] [Full-text]
247. Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes.
     J Clin Endocrinol Metab, 90(6): 3629-37. [Abstract] [Full-text]
248. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.
     J Clin Endocrinol Metab, 90(6): 3472-8. [Abstract] [Full-text]
249. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes.
     J Clin Endocrinol Metab, 90(6): 3387-91. [Abstract] [Full-text]
250. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.
     J Clin Endocrinol Metab, 90(6): 3174-8. [Abstract] [Full-text]
251. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients.
     J Clin Endocrinol Metab, 90(6): 3191-6. [Abstract] [Full-text]
252. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics.
     J Clin Endocrinol Metab, 90(6): 3665-72. [Abstract] [Full-text]
253. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.
     J Clin Endocrinol Metab, 90(6): 3287-94. [Abstract] [Full-text]
254. Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone.
     J Clin Endocrinol Metab, 90(6): 3423-6. [Abstract] [Full-text]
255. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
     Eur J Nucl Med Mol Imaging, 32(6): 647-52. [Abstract] [Full-text]
256. Cardiovascular endurance and heart rate variability in adolescents with type 1 or type 2 diabetes.
     Biol Res Nurs, 7(1): 16-29. [Abstract] [Full-text]
257. Population-based assessment of diabetes care and self-management among Puerto Rican adults in New York City.
     Diabetes Educ, 31(3): 418-26. [Abstract] [Full-text]
258. Barriers to diabetes education in urban patients: perceptions, patterns, and associated factors.
     Diabetes Educ, 31(3): 410-7. [Abstract] [Full-text]
259. Outcomes of border health Spanish/English chronic disease self-management programs.
     Diabetes Educ, 31(3): 401-9. [Abstract] [Full-text]
260. The frequency and behavioral outcomes of goal choices in the self-management of diabetes.
     Diabetes Educ, 31(3): 391-400. [Abstract] [Full-text]
261. Diabetes management in San Diego's Chamorro community.
     Diabetes Educ, 31(3): 379-90. [Abstract] [Full-text]
262. Diabetes educators: assessment of evolving practice.
     Diabetes Educ, 31(3): 359-72. [Abstract] [Full-text]
263. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
     Transplant Proc, 37(4): 1865-7. [Abstract] [Full-text]
264. Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.
     Transplant Proc, 37(4): 1857-60. [Abstract] [Full-text]
265. Factors influencing the onset of diabetes mellitus after kidney transplantation: a single French center experience.
     Transplant Proc, 37(4): 1851-6. [Abstract] [Full-text]
266. Long-term results of tacrolimus therapy for renal transplantation in patients with diabetic nephropathy in Japan.
     Transplant Proc, 37(4): 1767-8. [Abstract] [Full-text]
267. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study.
     BMJ, 330(7502): 1247. [Abstract] [Full-text]
268. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.
     Br J Ophthalmol, 89(6): 673-5. [Abstract] [Full-text]
269. Home-monitoring of blood glucose in cats with diabetes mellitus: evaluation over a 4-month period.
     J Feline Med Surg, 7(3): 163-71. [Abstract] [Full-text]
270. Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus.
     J Feline Med Surg, 7(3): 153-62. [Abstract] [Full-text]
271. Bacteria of food and human intestine are the most possible sources of the gad-trigger of type 1 diabetes.
     Med Hypotheses, 65(2): 308-11. [Abstract] [Full-text]
272. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
     Exp Clin Endocrinol Diabetes, 113(5): 298-301. [Abstract] [Full-text]
273. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
     Exp Clin Endocrinol Diabetes, 113(5): 288-91. [Abstract] [Full-text]
274. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
     Exp Clin Endocrinol Diabetes, 113(5): 282-7. [Abstract] [Full-text]
275. Complement activation in diabetic ketoacidosis and its treatment.
     Clin Immunol, 116(1): 11-7. [Abstract] [Full-text]
276. Increased superoxide production in hypertensive patients with diabetes mellitus: role of nitric oxide synthase.
     Am J Hypertens, 18(6): 839-43. [Abstract] [Full-text]
277. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics.
     Am J Hypertens, 18(6): 833-8. [Abstract] [Full-text]
278. Adherence to treatment: the key for avoiding long-term complications of diabetes.
     Arch Med Res, 36(3): 300-6. [Abstract] [Full-text]
279. Diabetes and pregnancy.
     Arch Med Res, 36(3): 291-9. [Abstract] [Full-text]
280. Diabetes mellitus in children and adolescents.
     Arch Med Res, 36(3): 281-90. [Abstract] [Full-text]
281. Islet transplantation: progress and challenge.
     Arch Med Res, 36(3): 273-80. [Abstract] [Full-text]
282. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants.
     Arch Med Res, 36(3): 250-7. [Abstract] [Full-text]
283. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.
     Arch Med Res, 36(3): 241-9. [Abstract] [Full-text]
284. Regulation of plasma triglycerides in insulin resistance and diabetes.
     Arch Med Res, 36(3): 232-40. [Abstract] [Full-text]
285. Genes and type 2 diabetes mellitus.
     Arch Med Res, 36(3): 210-22. [Abstract] [Full-text]
286. Pathogenesis of type 2 diabetes mellitus.
     Arch Med Res, 36(3): 197-209. [Abstract] [Full-text]
287. Epidemiology of type 2 diabetes in Mexico.
     Arch Med Res, 36(3): 188-96. [Abstract] [Full-text]
288. Glycemic control status in patients with type-2 diabetes.
     J Coll Physicians Surg Pak, 15(6): 323-5. [Abstract] [Full-text]
289. Insulin detemir, does a new century bring a better basal insulin?
     Int J Clin Pract, 59(6): 730-9. [Abstract] [Full-text]
290. Treatment for diabetic mononeuropathy with alpha-lipoic acid.
     Int J Clin Pract, 59(6): 645-50. [Abstract] [Full-text]
291. Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice.
     Int J Clin Pract, 59(6): 632-8. [Abstract] [Full-text]
292. Antidiabetic and antihyperlipemic effects of Clemeo felina.
     Fitoterapia, 76(3): 310-5. [Abstract] [Full-text]